Ultromics Raises 33M In Series B Funding To Help Transform Cardiac Disease Treatment
Led by Blue Venture Fund, new funding will accelerate Ultromics’ use of AI-enabled echocardiograms to improve patient outcomes OXFORD, England, Aug. 16, 2021 /PRNewswire/ — Ultromics, a leader in AI enabled cardiovascular imaging solutions, announced today that it has raised $33 million in a Series B funding round. The round was led by the Blue Venture Fund with participation from Optum Ventures, GV, and existing investor Oxford Sciences Innovation. Cardiovascular disease is the leading cause of mortality in the world, with an estimated 17 million deaths each year....